Document is current
Any future updates will be listed below
-
Authors
Melone, Viola
Salvati, Annamaria
Palumbo, Domenico
Giurato, Giorgio
Nassa, Giovanni
Rizzo, Francesca
Palo, Luigi
Giordano, Alessandro
Incoronato, Mariarosaria
Vitale, Mario
Mian, Caterina
Di Biase, Immacolata
Cristiano, Stefano
Narciso, Viviana
Cantile, Monica
Di Mauro, Annabella
Tatangelo, Fabiana
Tafuto, Salvatore
Modica, Roberta
Pivonello, Claudia
Salvatore, Marco
Colao, Annamaria
Weisz, Alessandro
Tarallo, Roberta https://orcid.org/0000-0001-9668-3632
-
Funding
Funding for this research was provided by:
Regione Campania (B63D18000380007, B41C17000080007)
Università degli Studi di Salerno (ORSA195102)
- License Information
-
More Information
Article History
Received: 20 May 2022
Accepted: 28 June 2022
First Online: 6 July 2022
Declarations
:
: The study was performed in accordance with the Declaration of Helsinki. All patients provided written informed consent for the use of tumor samples, according to the institutional regulations and the study was approved by the ethics committee of the National Cancer Institute “G. Pascale” (Project name: “Fighting Cancer resistance: Multidisciplinary integrated Platform for a technological Innovative Approach to Oncotherapies (Campania Oncotherapies)”—Ethical approval no. 40/19 OSS—Date 2019 November 21) and by the ethical committee of Federico II University of Naples (Project name: Innovazioni diagnostiche e terapeutiche per tumori neuroendocrini, endocrini e per il glioblastoma—Ethical approval no. 223/19—Date 2019 July 16).
: Not applicable.
: The authors declare that they have no competing interests<b>.</b>
